This inventor holds 4 USPTO granted patents and 4 published patent applications and 4 EPO patents. Top assignees: Genentech, Inc., Constellation Pharmaceuticals, Inc., Harbin Zhenbao Pharmaceutical Co., Ltd.. Active years: 2017-2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
3 out of 3,300 
1 out of 56 
1 out of 4 Years Active: 2017-2021
Sure, here is an article about inventor Jiangpeng Liao:
Title: Innovator Spotlight: Jiangpeng Liao - Pioneering Estrogen Receptor Modulators
Introduction:
Jiangpeng Liao, a brilliant inventor based in Shanghai, China, is making waves in the field of pharmaceuticals with his groundbreaking work in developing estrogen receptor modulators. With a knack for innovation and a passion for advancing medical science, Liao has secured four patents and is showing no signs of slowing down.
Latest Patents:
Liao's latest patents include cutting-edge discoveries in the realm of estrogen receptor modulators. From tetrahydro-pyrido[3,4-b]indole compounds to heteroaryl structures, his inventions have the potential to revolutionize the treatment of diseases and conditions reliant on estrogen receptors. His meticulous formulations and pharmaceutical compositions are paving the way for more effective therapies and improved patient outcomes.
Career Highlights:
Having worked with esteemed companies such as Genentech, Inc. and Constellation Pharmaceuticals, Inc., Jiangpeng Liao has honed his expertise and sharpened his skills in drug development and molecular biology. His contributions to the industry have been widely recognized, solidifying his reputation as a trailblazer in the pharmaceutical sector.
Collaborations:
Liao's collaborative spirit is evident in his partnerships with esteemed colleagues such as Sharada Shenvi Labadie and Jun Liang. Together, they have pushed the boundaries of innovation and crafted novel solutions to pressing medical challenges. Through teamwork and shared vision, these innovators are shaping the future of healthcare.
Conclusion:
In conclusion, Jiangpeng Liao stands at the forefront of pharmaceutical innovation, driving progress and ushering in a new era of medical advancements. His dedication to research, coupled with his creative ingenuity, has positioned him as a leader in the field. With four patents to his name and a wealth of knowledge at his disposal, Liao is set to make even greater strides in the realm of estrogen receptor modulation.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile